Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Lung Neoplasms 4Oropharyngeal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Mouth Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Colorectal Neoplasms 2Carcinoma 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stage II Prostate Adenocarcinoma 1Sarcoma, Ewing 1Renal Pelvis and Ureter Urothelial Carcinoma 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Nasopharyngeal Carcinoma 1Muscle Invasive Bladder Urothelial Carcinoma 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, B-Cell, Marginal Zone 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Receptors, Bombesin 1Magnetic Resonance Spectroscopy 1Gallium 1BAY 86-7548 168Ga-bombesin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Prostate Adenocarcinoma × Magnetic Resonance Spectroscopy × Clear all
NCT02624518 2023-04-10

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Stanford University

Phase 2/3 Completed
122 enrolled 8 charts
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡